« Older Entries
Henri Termeer joins Prosensa as Strategic Advisor
Thursday, December 13th, 2012
Leiden, The Netherlands – 13 December 2012 – Prosensa, the Dutch biopharmaceutical company focusing on RNA-modulating therapeutics for rare diseases with high unmet need, has appointed industry leader and former Genz [...]
BioCapitalEurope 2013
Tuesday, November 20th, 2012
BioCapitalEurope
Wednesday 17th April 2013
BioCapital Europe 2013, organised by LSP (Life Sciences Partners) and ABN AMRO, is delighted to announce its 11th consecutive event, taking place on Wednesday 17th April 2 [...]
Kiadis Pharma Raises EUR 10 Million in Financing Round
Tuesday, November 20th, 2012
Amsterdam, The Netherlands, November 20, 2012 – Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing treatments for blood cancers, announced today that it has raised EUR 10 million in an equity fin [...]
arGEN-X appoints Dr. David L. Lacey to its Supervisory Board
Thursday, October 25th, 2012
Breda, the Netherlands and Ghent, Belgium October; 25 October 2012 – arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody™ [...]
« Older Entries